Intermediates for specific 5-HT3 antagonists

Details Intermediates for specific 5-HT3 antagonists Intermediates for specific 5-HT3 antagonists

1994-06-22

1995-08-15

Dentz, Bernard

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C07D33506

Patent

active

054420784

ABSTRACT:
This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.

REFERENCES:
patent: 3860619 (1975-01-01), Christensen et al.
patent: 4329459 (1982-05-01), McCall
patent: 4486441 (1984-12-01), Fozard et al.
patent: 4895868 (1990-01-01), Chandraratna et al.
Gazz. Chim. Ital., 3(9-10), 383 (1981).
Occelli et al., Chem. Abst., vol. 96, 142391 (1982).
Rorer, Chem. Abst., vol. 99, 53792 (1983).
Christensen et al., Chem. Abst. (II), vol. 78, 147774 (1973).
Serban et al., Chem. Abst., vol. 84, 59722 (1976).

Affiliated with

Also associated with

Rating

Intermediates for specific 5-HT3 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intermediates for specific 5-HT3 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediates for specific 5-HT3 antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2182765